A critical breakthrough in cancer investigation is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer suppressor protein is frequently inactivated in various types of tumors, https://bookmarksurl.com/story7638065/mini-antibodies-restore-tumor-suppressor-p53-the-promising-hope-for-malignant-therapy